|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.56 CNY | +4.35% |
|
+2.28% | -7.03% |
| 07-01 | Tranche Update on Tibet Rhodiola Pharmaceutical Holding Co.'s Equity Buyback Plan announced on December 18, 2025. | CI |
| 05-08 | Tibet Rhodiola Pharmaceutical Holding's board elects chairman | RE |
| Market Cap | 12.59B 1.87B 1.62B 1.51B 1.39B 2.61B 178B 2.64B 17.75B 6.96B 89.36B 7.02B 6.87B 295B | P/E 2024 |
11.3x | P/E 2025 | 14.6x |
|---|---|---|---|---|---|
| Enterprise Value | 9.98B 1.48B 1.28B 1.2B 1.1B 2.07B 141B 2.1B 14.07B 5.52B 70.85B 5.56B 5.44B 234B | EV / Sales 2024 |
3.4x | EV / Sales 2025 | 3.72x |
| Free-Float |
39.36% | Yield 2024 |
5.3% | Yield 2025 | 4.13% |
| 1 day | +4.35% | ||
| 1 week | +2.28% | ||
| Current month | +2.28% | ||
| 1 month | +5.30% | ||
| 3 months | -5.36% | ||
| 6 months | -7.51% | ||
| Current year | -7.03% |
| 1 week | 37.58 |  | 39.69 |
| 1 month | 36.61 | | 40.7 |
| Current year | 34.8 | | 46 |
| 1 year | 34.8 | | 57.98 |
| 3 years | 26.95 | | 57.98 |
| 5 years | 22.73 | | 57.98 |
| 10 years | 13.54 | | 140.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yuan Dong Guo
CEO | Chief Executive Officer | 56 | 20/11/2014 |
Jun Chen
DFI | Director of Finance/CFO | 48 | 25/10/2019 |
Li Li Wen
IRC | Investor Relations Contact | 46 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Da Bin Chen
CHM | Chairman | 70 | 08/01/2015 |
Yu Cheng Zhou
BRD | Director/Board Member | 44 | 08/01/2015 |
Yuan Dong Guo
BRD | Director/Board Member | 56 | 08/01/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.35% | +2.28% | -4.81% | +4.83% | 1.87B | |
| -0.52% | +3.21% | +85.02% | +161.12% | 1,057B | |
| +0.88% | +1.13% | +51.13% | +49.76% | 625B | |
| +0.89% | -1.95% | +23.73% | +63.67% | 435B | |
| +0.71% | +3.87% | +47.45% | +38.68% | 363B | |
| +0.64% | -0.49% | +35.39% | +40.21% | 296B | |
| +0.39% | -5.83% | +8.64% | +9.28% | 249B | |
| +1.51% | +6.69% | +44.34% | +62.47% | 222B | |
| +3.92% | -0.46% | -1.21% | -44.09% | 209B | |
| +1.80% | +2.30% | +20.79% | +65.13% | 165B | |
| Average | +1.46% | +0.91% | +31.05% | +45.11% | 362.27B | |
| Weighted average by Cap. | +0.66% | +1.22% | +48.31% | +75.30% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.81B 417M 361M 337M 309M 582M 39.66B 589M 3.96B 1.55B 19.92B 1.56B 1.53B 65.72B | 2.98B 443M 384M 358M 329M 618M 42.13B 626M 4.2B 1.65B 21.16B 1.66B 1.63B 69.81B |
| Net income | 1.05B 156M 135M 126M 116M 218M 14.86B 221M 1.48B 581M 7.46B 586M 573M 24.61B | 938M 139M 121M 113M 103M 194M 13.25B 197M 1.32B 518M 6.66B 523M 511M 21.96B |
| Net Debt | -2.35B -349M -303M -282M -259M -488M -33.23B -494M -3.31B -1.3B -16.69B -1.31B -1.28B -55.06B | -2.61B -387M -336M -313M -288M -541M -36.86B -548M -3.68B -1.44B -18.51B -1.45B -1.42B -61.08B |
Employees
671
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/08/26 | CN¥39.56 | +4.35% | 6,087,254 |
| 06/08/26 | CN¥37.91 | -1.79% | 3,319,810 |
| 05/08/26 | CN¥38.60 | -1.28% | 3,539,007 |
| 04/08/26 | CN¥39.10 | +0.13% | 3,257,458 |
| 03/08/26 | CN¥39.05 | +0.96% | 2,589,857 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600211 Stock
Select your edition
All financial news and data tailored to specific country editions
